» Articles » PMID: 31464551

Mobilize to Vaccinate: Lessons Learned from Social Mobilization for Immunization in Low and Middle-income Countries

Overview
Date 2019 Aug 30
PMID 31464551
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Creating and sustaining demand for immunization services is a global priority to ensure that vaccine-eligible populations are fully protected from vaccine-preventable diseases. Social mobilization remains a key health promotion strategy used by low- and middle-income countries (LMICs) to promote vaccination demand. In this commentary, we synthesize illustrative evidence on successful social mobilization efforts promoting the uptake of immunization services in select LMICs. The first example focuses on Sierra Leone's routine immunization program during the Universal Child Immunization initiative in the late 1980s. We then give an example of India's establishment of a social mobilization network in the early- to mid-2000s to support polio elimination in high-risk communities. Thirdly, we highlight the complexities of social mobilization in a humanitarian emergency during the 2017-2018 diphtheria outbreak among displaced Rohingyas in camps and settlements in Bangladesh. Lastly, we draw upon examples from the introduction of the human papillomavirus vaccine in several countries. We then critically examine recurring challenges faced when implementing social mobilization for immunization in LMICs and offer practical recommendations for improvement.

Citing Articles

Understanding the Challenges of Advocacy Communication, Social Mobilization, and Operationalization for COVID-19 and Routine Immunization in Nigeria.

Isiaka S, Asaolu S, Gab-Deedam S, Jimoh A, Samuel O, Sampson S Am J Trop Med Hyg. 2024; 112(2):364-372.

PMID: 39561394 PMC: 11803647. DOI: 10.4269/ajtmh.24-0282.


Health service providers' views on barriers and drivers to childhood vaccination of FDMN/Rohingya refugees: a qualitative study in Cox's Bazar, Bangladesh.

Reda S, Weishaar H, Akhter S, Karo B, Martinez J, Singh A Front Public Health. 2024; 12:1359082.

PMID: 39045160 PMC: 11265221. DOI: 10.3389/fpubh.2024.1359082.


A World without Measles and Rubella: Addressing the Challenge of Vaccine Hesitancy.

Higgins D, OLeary S Vaccines (Basel). 2024; 12(6).

PMID: 38932423 PMC: 11209163. DOI: 10.3390/vaccines12060694.


Enablers and barriers to rotavirus vaccine coverage in Assam, India- A qualitative study.

Mehra R, Ray A, Das S, Biman Kusum Chowdhury , Koshal S, Hora R Vaccine X. 2024; 18:100479.

PMID: 38559753 PMC: 10979257. DOI: 10.1016/j.jvacx.2024.100479.


Deployment of novel oral polio vaccine type 2 under emergency use listing in Nigeria: the rollout experience.

Asekun A, Nkwogu L, Bawa S, Usman S, Edukugho A, Ocheh J Pan Afr Med J. 2024; 45(Suppl 2):3.

PMID: 38370105 PMC: 10874098. DOI: 10.11604/pamj.supp.2023.45.2.38033.


References
1.
Deutsch N, Singh P, Singh V, Curtis R, Siddique A . Legacy of Polio-Use of India's Social Mobilization Network for Strengthening of the Universal Immunization Program in India. J Infect Dis. 2017; 216(suppl_1):S260-S266. PMC: 5854010. DOI: 10.1093/infdis/jix068. View

2.
Zarocostas J . UNICEF taps religious leaders in vaccination push. Lancet. 2004; 363(9422):1709. DOI: 10.1016/S0140-6736(04)16294-6. View

3.
Obregon R, Waisbord S . The complexity of social mobilization in health communication: top-down and bottom-up experiences in polio eradication. J Health Commun. 2010; 15 Suppl 1:25-47. DOI: 10.1080/10810731003695367. View

4.
Berlier M, Barry R, Shadid J, Sirica C, Brunier A, Hasan H . Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa. Clin Infect Dis. 2015; 61 Suppl 5:S451-8. PMC: 4639482. DOI: 10.1093/cid/civ493. View

5.
Cover J, Nghi N, Scott Lamontagne D, Huyen D, Hien N, Nga L . Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health. 2012; 12:629. PMC: 3437216. DOI: 10.1186/1471-2458-12-629. View